“抑木扶土”调节肠道菌群治疗T2DM伴焦虑抑郁的机制
The Mechanism of Regulating Intestinal Flora by “Inhibiting Wood and Strengthening Earth” in the Treatment of T2DM with Anxiety and Depression
DOI: 10.12677/tcm.2026.152093, PDF,   
作者: 梅 子:成都中医药大学临床医学院,四川 成都;龚光明*:成都中医药大学附属医院内分泌科,四川 成都
关键词: 2型糖尿病肠道菌群焦虑抑郁抑木扶土中医治法Type 2 Diabetes Intestinal Flora Anxiety and Depression Inhibiting Wood and Strengthening Earth Traditional Chinese Medical Treatment
摘要: 2型糖尿病(type 2 diabetes mellitus, T2DM)是以高血糖为特征的慢性进行性疾病,常伴随焦虑、抑郁等情绪障碍,严重影响患者生活质量。近年来研究发现,肠道菌群与T2DM及情绪障碍的发生发展存在着密切联系,通过“肠–脑轴”调节、神经递质、免疫炎症反应等途径影响糖尿病患者的焦虑、抑郁心理。中医学认为,脾虚失运、肝失疏泄是T2DM合并焦虑抑郁的核心病机,抑木扶土法通过调和肝脾,恢复气机升降,既可改善糖脂代谢,又能调节情志活动。现代研究提示,抑木扶土法能够改善肠屏障功能、恢复肠道微生物稳态,故本文从“肠道菌群”理论出发,将中医“抑木扶土”法理论与其有机结合,剖析其调控肠道菌群从而改善T2DM合并焦虑抑郁的科学机制,以期为T2DM合并焦虑抑郁的中医临床诊疗提供新的思路及理论依据。
Abstract: Type 2 diabetes mellitus (T2DM) is a chronic progressive disease characterized by high blood sugar, often accompanied by emotional disorders such as anxiety and depression, which significantly affect the quality of life of patients. Recent studies have found that the gut microbiota is closely related to the occurrence and development of T2DM and emotional disorders. Through pathways such as the “gut-brain axis” regulation, neurotransmitters, and immune inflammatory responses, it affects the anxiety and depression of diabetic patients. In traditional Chinese medicine, spleen deficiency and failure of transportation, as well as liver failure in regulating secretion, are the core pathogenesis of T2DM combined with anxiety and depression. The method of restraining the liver and supporting the spleen can restore the balance of qi circulation and improve both sugar and lipid metabolism, as well as regulate emotional activities. Modern research suggests that the method of restraining the liver and supporting the spleen can improve intestinal barrier function and restore the stability of intestinal microbiota. Therefore, this article, based on the theory of “gut microbiota”, combines the theory of “restraining the liver and supporting the spleen” from traditional Chinese medicine and analyzes the scientific mechanism of regulating the gut microbiota to improve T2DM combined with anxiety and depression, in order to provide new ideas and theoretical basis for the clinical diagnosis and treatment of T2DM combined with anxiety and depression.
文章引用:梅子, 龚光明. “抑木扶土”调节肠道菌群治疗T2DM伴焦虑抑郁的机制[J]. 中医学, 2026, 15(2): 190-197. https://doi.org/10.12677/tcm.2026.152093

参考文献

[1] Farooqi, A., Gillies, C., Sathanapally, H., Abner, S., Seidu, S., Davies, M.J., et al. (2022) A Systematic Review and Meta-Analysis to Compare the Prevalence of Depression between People with and without Type 1 and Type 2 Diabetes. Primary Care Diabetes, 16, 1-10. [Google Scholar] [CrossRef] [PubMed]
[2] Rafael, B., Horváth, L., Szemán, F., Várkonyi, T., Lengyel, C. and Dávid, A. (2022) A diabetes mellitus kapcsolata a depresszióval, a szorongással és az életminőséggel. Orvosi Hetilap, 163, 1789-1797. [Google Scholar] [CrossRef] [PubMed]
[3] Huang, C., Hsieh, H., Tu, H., Jiang, H., Wang, P. and Lin, C. (2020) Generalized Anxiety Disorder in Type 2 Diabetes Mellitus: Prevalence and Clinical Characteristics. Brazilian Journal of Psychiatry, 42, 621-629. [Google Scholar] [CrossRef] [PubMed]
[4] Asman, A.G., Hoogendoorn, C.J., McKee, M.D. and Gonzalez, J.S. (2019) Assessing the Association of Depression and Anxiety with Symptom Reporting among Individuals with Type 2 Diabetes. Journal of Behavioral Medicine, 43, 57-68. [Google Scholar] [CrossRef] [PubMed]
[5] 李肖, 宫文霞, 周玉枝, 等. 逍遥散中抗抑郁有效成分及其作用机制研究进展[J]. 中草药, 2015, 46(20): 3109-3116.
[6] Kivimäki, M., Hamer, M., Batty, G.D., Geddes, J.R., Tabak, A.G., Pentti, J., et al. (2010) Antidepressant Medication Use, Weight Gain, and Risk of Type 2 Diabetes: A Population-Based Study. Diabetes Care, 33, 2611-2616. [Google Scholar] [CrossRef] [PubMed]
[7] Goodnick, P.J. (1995) Treatment of Depression in Patients with Diabetes Mellitus. Southern Medical Journal, 88, S59. [Google Scholar] [CrossRef
[8] Bhattacharjee, S., Bhattacharya, R., Kelley, G.A. and Sambamoorthi, U. (2013) Antidepressant Use and New‐Onset Diabetes: A Systematic Review and Meta‐Analysis. Diabetes/Metabolism Research and Reviews, 29, 273-284. [Google Scholar] [CrossRef] [PubMed]
[9] 黄爱娟. 肠道菌群在2型糖尿病伴焦虑抑郁状态(肝郁脾虚证)中的相关作用研究[D]: [硕士学位论文]. 郑州: 河南中医药大学, 2022.
[10] Massier, L., Blüher, M., Kovacs, P. and Chakaroun, R.M. (2021) Impaired Intestinal Barrier and Tissue Bacteria: Pathomechanisms for Metabolic Diseases. Frontiers in Endocrinology, 12, Article 646506. [Google Scholar] [CrossRef] [PubMed]
[11] Sharma, S. and Tripathi, P. (2019) Gut Microbiome and Type 2 Diabetes: Where We Are and Where to Go? The Journal of Nutritional Biochemistry, 63, 101-108. [Google Scholar] [CrossRef] [PubMed]
[12] Lee, C.J., Sears, C.L. and Maruthur, N. (2019) Gut Microbiome and Its Role in Obesity and Insulin Resistance. Annals of the New York Academy of Sciences, 1461, 37-52. [Google Scholar] [CrossRef] [PubMed]
[13] Sedighi, M., Razavi, S., Navab-Moghadam, F., Khamseh, M.E., Alaei-Shahmiri, F., Mehrtash, A., et al. (2017) Comparison of Gut Microbiota in Adult Patients with Type 2 Diabetes and Healthy Individuals. Microbial Pathogenesis, 111, 362-369. [Google Scholar] [CrossRef] [PubMed]
[14] Dash, N.R., Al Bataineh, M.T., Alili, R., Al Safar, H., Alkhayyal, N., Prifti, E., et al. (2023) Functional Alterations and Predictive Capacity of Gut Microbiome in Type 2 Diabetes. Scientific Reports, 13, Article No. 22386. [Google Scholar] [CrossRef] [PubMed]
[15] Lê, K., Li, Y., Xu, X., Yang, W., Liu, T., Zhao, X., et al. (2013) Alterations in Fecal Lactobacillus and Bifidobacterium Species in Type 2 Diabetic Patients in Southern China Population. Frontiers in Physiology, 3, Article 496. [Google Scholar] [CrossRef] [PubMed]
[16] Song, Z., Yan, A., Guo, Z., Zhang, Y., Wen, T., Li, Z., et al. (2023) Targeting Metabolic Pathways: A Novel Therapeutic Direction for Type 2 Diabetes. Frontiers in Cellular and Infection Microbiology, 13, Article 1218326. [Google Scholar] [CrossRef] [PubMed]
[17] Sawicki, C., Livingston, K., Obin, M., Roberts, S., Chung, M. and McKeown, N. (2017) Dietary Fiber and the Human Gut Microbiota: Application of Evidence Mapping Methodology. Nutrients, 9, Article 125. [Google Scholar] [CrossRef] [PubMed]
[18] Tan, J., McKenzie, C., Potamitis, M., Thorburn, A.N., Mackay, C.R. and Macia, L. (2014) The Role of Short-Chain Fatty Acids in Health and Disease. Advances in Immunology, 121, 91-119. [Google Scholar] [CrossRef] [PubMed]
[19] Yu, H., Nie, R. and Shen, C. (2023) The Role of Bile Acids in Regulating Glucose and Lipid Metabolism. Endocrine Journal, 70, 359-374. [Google Scholar] [CrossRef] [PubMed]
[20] Hou, Y., Zhai, X., Wang, X., Wu, Y., Wang, H., Qin, Y., et al. (2023) Research Progress on the Relationship between Bile Acid Metabolism and Type 2 Diabetes Mellitus. Diabetology & Metabolic Syndrome, 15, Article No. 235. [Google Scholar] [CrossRef] [PubMed]
[21] Nguyen, A.T., Mandard, S., Dray, C., Deckert, V., Valet, P., Besnard, P., et al. (2014) Lipopolysaccharides-Mediated Increase in Glucose-Stimulated Insulin Secretion: Involvement of the GLP-1 Pathway. Diabetes, 63, 471-482. [Google Scholar] [CrossRef] [PubMed]
[22] Chang, L., Wei, Y. and Hashimoto, K. (2022) Brain-Gut-Microbiota Axis in Depression: A Historical Overview and Future Directions. Brain Research Bulletin, 182, 44-56. [Google Scholar] [CrossRef] [PubMed]
[23] Xiao, W., Su, J., Gao, X., Yang, H., Weng, R., Ni, W., et al. (2022) The Microbiota-Gut-Brain Axis Participates in Chronic Cerebral Hypoperfusion by Disrupting the Metabolism of Short-Chain Fatty Acids. Microbiome, 10, Article No. 62. [Google Scholar] [CrossRef] [PubMed]
[24] 郇鹏飞, 金智生. 肠道菌群在2型糖尿病并发抑郁症中的作用探析[J]. 中国微生态学杂志, 2020, 32(6): 731-733, 740.
[25] Liu, Y., Wang, H., Gui, S., Zeng, B., Pu, J., Zheng, P., et al. (2021) Proteomics Analysis of the Gut-Brain Axis in a Gut Microbiota-Dysbiosis Model of Depression. Translational Psychiatry, 11, Article No. 568. [Google Scholar] [CrossRef] [PubMed]
[26] Tayab, M.A., Islam, M.N., Chowdhury, K.A.A. and Tasnim, F.M. (2022) Targeting Neuroinflammation by Polyphenols: A Promising Therapeutic Approach against Inflammation-Associated Depression. Biomedicine & Pharmacotherapy, 147, Article ID: 112668. [Google Scholar] [CrossRef] [PubMed]
[27] 刘小溪, 李小娟, 石岩, 等. 益气补脾法配合二甲双胍干预脾虚证2型糖尿病患者肠道菌群的临床研究. 辽宁中医杂志, 2017, 44(11): 2311-2313.
[28] Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., et al. (2009) Changes in Gut Microbiota Control Inflammation in Obese Mice through a Mechanism Involving GLP-2-Driven Improvement of Gut Permeability. Gut, 58, 1091-1103. [Google Scholar] [CrossRef] [PubMed]
[29] 刘名波. 香砂六君子汤对脾虚泄泻免疫功能和肠道微生态的影响[D]: [硕士学位论文]. 苏州: 苏州大学, 2015.
[30] 赵璠, 刘文俊, 陈伟仁, 等. 基于结肠黏膜JAK2/STAT3通路研究健脾化痰法的作用机制. 中华中医药学刊, 2018, 36(6): 1411-1413.
[31] Wang, J., Bose, S., Kim, H., Han, K. and Kim, H. (2015) Fermented Rhizoma Atractylodis macrocephalae Alleviates High Fat Diet-Induced Obesity in Association with Regulation of Intestinal Permeability and Microbiota in Rats. Scientific Reports, 5, Article No. 8391. [Google Scholar] [CrossRef] [PubMed]
[32] Chen, Y., Bai, J., Wu, D., Yu, S., Qiang, X., Bai, H., et al. (2019) Association between Fecal Microbiota and Generalized Anxiety Disorder: Severity and Early Treatment Response. Journal of Affective Disorders, 259, 56-66. [Google Scholar] [CrossRef] [PubMed]
[33] Liśkiewicz, P., Kaczmarczyk, M., Misiak, B., Wroński, M., Bąba-Kubiś, A., Skonieczna-Żydecka, K., et al. (2021) Analysis of Gut Microbiota and Intestinal Integrity Markers of Inpatients with Major Depressive Disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 106, Article ID: 110076. [Google Scholar] [CrossRef] [PubMed]
[34] 蔡师敏. 糖尿病与情志变化探析[J]. 实用中医药杂志, 2005(1): 43.
[35] 刘星, 梁煊, 李斌, 等. 基于肠道菌群和代谢组学探讨疏肝化滞方对糖尿病合并代谢相关脂肪性肝病的影响[J]. 新发传染病电子杂志, 2025, 10(3): 29-39.
[36] 吴佳佳. 逍遥散对肠道菌群失调小鼠神经炎症及结肠上皮屏障的保护作用[D]: [博士学位论文]. 北京: 北京中医药大学, 2020.
[37] 王淑静, 谷松. 乌梅丸抑木扶土辨治厥阴证诸病[J]. 中国药物经济学, 2021, 16(2): 125-128.
[38] 严俊宁, 宋文杰, 张倍嘉, 等. 乌梅丸治疗2型糖尿病的机理探讨[J]. 中国民族民间医药, 2022, 31(17): 7-10.
[39] 徐锋, 刘蓉, 曾南. 逍遥散及其衍生方治疗糖尿病及伴抑郁症的研究现状[J]. 中药药理与临床, 2016, 32(1): 219-223.
[40] 李芳芳, 康学东. 加味逍遥散治疗肝郁脾虚型2型糖尿病伴情绪障碍患者的临床观察[J]. 中国实验方剂学杂志, 2019, 25(2): 134-138.
[41] 宋美芳. 从胆汁酸-TGR5-GLP-1通路探讨抑郁模型大鼠糖代谢异常及逍遥散的作用机理[D]: [硕士学位论文]. 北京: 北京中医药大学, 2019.
[42] 张琪, 杜顺棠, 季兵, 刘峰. 四逆散合甘麦大枣汤治疗2型糖尿病合并抑郁焦虑状态临床观察[J]. 广州中医药大学学报, 2022, 39(4): 763-769
[43] 郭强, 赵欢, 朱玉霞, 等. 抑木扶土法治疗2型糖尿病合并抑郁症疗效的Meta分析[J]. 山东医药, 2015, 55(26): 17-21.